In this video from CDHFtube we find out more about biologics and what their role is in the treatment of inflammatory bowel disease (IBD). Biologics are beneficial antibodies made from ... Read more
Phase 2 clinical trial results showed that patients with moderate to severe active Crohn’s disease can achieve disease remission when treated with risankizumab, a Boehringer Ingelheim investigational biologic product. The study, “IL-23 ... Read more
